Avanos Medical (NYSE:AVNS) Sets New 1-Year Low – Should You Sell?

Avanos Medical, Inc. (NYSE:AVNS) shares hit a new 52-week low on Monday . The company traded as low as $15.51 and last traded at $15.65, with a volume of 460319 shares trading hands. The stock had previously closed at $15.55.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Trading Up 0.5 %

The firm has a market capitalization of $717.85 million, a P/E ratio of 45.94 and a beta of 0.99. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The stock has a 50 day simple moving average of $18.33 and a 200-day simple moving average of $21.05.

Institutional Trading of Avanos Medical

Large investors have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company grew its position in shares of Avanos Medical by 3.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock valued at $341,000 after acquiring an additional 590 shares during the period. KBC Group NV lifted its position in Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares in the last quarter. New York State Teachers Retirement System grew its holdings in Avanos Medical by 2.0% during the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock valued at $1,737,000 after purchasing an additional 1,388 shares during the period. Quarry LP purchased a new stake in Avanos Medical in the third quarter worth about $42,000. Finally, Foundry Partners LLC raised its stake in shares of Avanos Medical by 1.1% in the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock worth $3,918,000 after buying an additional 1,800 shares during the period. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.